跳至主要内容
临床试验/CTRI/2021/09/036397
CTRI/2021/09/036397尚未招募未知

A prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

Prof Dr med Thorsten Khn0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Signed informed consent form
  • - Primary invasive breast cancer (confirmed by core biopsy)
  • - cN+ (confirmed by core biopsy/fine needle aspiration or presence of highly suspicious axillary node[s] on imaging)
  • - In case a minimally invasive biopsy of axillary lymph node(s) has been performed and yielded a negative or inconclusive result, patients may be included if the final classification after imaging-pathology-correlation is cN+
  • - cT1-cT4c
  • - Scheduled for neoadjuvant systemic therapy
  • - Female / male patients >= 18 years old

排除标准

  • Distant metastasis
  • - Recurrent breast cancer
  • - Inflammatory breast cancer
  • - Extramammary breast cancer
  • - Bilateral breast cancer
  • - History of invasive breast cancer, DCIS or any other invasive cancer
  • - Confirmed or suspected supraclavicular lymph node metastasis
  • - Confirmed or suspected parasternal lymph node metastasis
  • - Axillary surgery before NACT (e.g. SLNB or nodal sampling)
  • - Pregnancy
  • - Less than 4 cycles of NACT administered
  • - Patients not suitable for surgical treatment

研究者

发起方
Prof Dr med Thorsten Khn

相似试验